EMJ Cardiology 10 [Supplement 3] . 2022

Highlighting a plenary session that took place at the European Atherosclerosis Society (EAS), this article summarises the groundbreaking research and personalised approach to atherosclerotic cardiovascular disease. The presenters covered the deep phenotyping of atherosclerotic disease, including the use of single-cell technologies, to understand the immune mechanisms involved in cardiovascular disease.